These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1101 related items for PubMed ID: 16277686

  • 21. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression.
    Migita H, Morser J.
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):710-6. PubMed ID: 15662020
    [Abstract] [Full Text] [Related]

  • 22. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB, Keelan JA, Helliwell RJ, Gilmour RS, Mitchell MD.
    Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD, Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon HJ, Sohn J, Song GG.
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [Abstract] [Full Text] [Related]

  • 24. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway.
    Boyault S, Bianchi A, Moulin D, Morin S, Francois M, Netter P, Terlain B, Bordji K.
    FEBS Lett; 2004 Aug 13; 572(1-3):33-40. PubMed ID: 15304320
    [Abstract] [Full Text] [Related]

  • 25. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.
    Phulwani NK, Feinstein DL, Gavrilyuk V, Akar C, Kielian T.
    J Neurochem; 2006 Dec 13; 99(5):1389-1402. PubMed ID: 17074064
    [Abstract] [Full Text] [Related]

  • 26. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY, Tseng CC.
    Mol Pharmacol; 2005 Nov 13; 68(5):1203-13. PubMed ID: 16077033
    [Abstract] [Full Text] [Related]

  • 27. 15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms.
    Bernardo A, Ajmone-Cat MA, Levi G, Minghetti L.
    J Neurochem; 2003 Nov 13; 87(3):742-51. PubMed ID: 14535956
    [Abstract] [Full Text] [Related]

  • 28. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts.
    Lin TH, Tang CH, Wu K, Fong YC, Yang RS, Fu WM.
    J Cell Physiol; 2011 Dec 13; 226(12):3242-50. PubMed ID: 21344384
    [Abstract] [Full Text] [Related]

  • 29. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
    Ray DM, Akbiyik F, Phipps RP.
    J Immunol; 2006 Oct 15; 177(8):5068-76. PubMed ID: 17015690
    [Abstract] [Full Text] [Related]

  • 30. 15-Deoxy-Δ(12,14)-prostaglandin J(2) modulates lipopolysaccharide-induced chemokine expression by blocking nuclear factor-κB activation via peroxisome proliferator activated receptor-γ-independent mechanism in renal tubular epithelial cells.
    Lu Y, Zhou Q, Zhong F, Guo S, Hao X, Li C, Wang W, Chen N.
    Nephron Exp Nephrol; 2013 Oct 15; 123(1-2):1-10. PubMed ID: 23887394
    [Abstract] [Full Text] [Related]

  • 31. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R, Koeffler HP.
    Int J Oncol; 2004 Aug 15; 25(2):493-502. PubMed ID: 15254749
    [Abstract] [Full Text] [Related]

  • 32. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
    Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, Chatterjee PK, Thiemermann C.
    FASEB J; 2002 Jul 15; 16(9):1027-40. PubMed ID: 12087064
    [Abstract] [Full Text] [Related]

  • 33. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J, Xia Q, Zhang Q, Li H, Zhang J, Li A, Xiu R.
    Shock; 2009 Sep 15; 32(3):317-24. PubMed ID: 19174742
    [Abstract] [Full Text] [Related]

  • 34. PPAR gamma ligands, 15-deoxy-delta12,14-prostaglandin J2 and rosiglitazone regulate human cultured airway smooth muscle proliferation through different mechanisms.
    Ward JE, Gould H, Harris T, Bonacci JV, Stewart AG.
    Br J Pharmacol; 2004 Feb 15; 141(3):517-25. PubMed ID: 14718259
    [Abstract] [Full Text] [Related]

  • 35. 15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism.
    Hinz B, Brune K, Pahl A.
    Biochem Biophys Res Commun; 2003 Mar 07; 302(2):415-20. PubMed ID: 12604364
    [Abstract] [Full Text] [Related]

  • 36. 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury.
    Lin TN, Cheung WM, Wu JS, Chen JJ, Lin H, Chen JJ, Liou JY, Shyue SK, Wu KK.
    Arterioscler Thromb Vasc Biol; 2006 Mar 07; 26(3):481-7. PubMed ID: 16385084
    [Abstract] [Full Text] [Related]

  • 37. A natural PPAR-gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, may act as an enhancer of PAI-1 in human proximal renal tubular cells under hypoxic and inflammatory conditions.
    Kimura H, Li X, Torii K, Okada T, Takahashi N, Fujii H, Ishihara S, Yoshida H.
    Nephrol Dial Transplant; 2008 Aug 07; 23(8):2496-503. PubMed ID: 18367541
    [Abstract] [Full Text] [Related]

  • 38. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
    Polikandriotis JA, Mazzella LJ, Rupnow HL, Hart CM.
    Arterioscler Thromb Vasc Biol; 2005 Sep 07; 25(9):1810-6. PubMed ID: 16020752
    [Abstract] [Full Text] [Related]

  • 39. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
    Kang DS, Kwon CH, Park JY, Kim JH, Woo JS, Jung JS, Kim YK.
    Toxicol Appl Pharmacol; 2006 Nov 01; 216(3):426-35. PubMed ID: 16890972
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of coexpression of microsomal prostaglandin E synthase-1 and cyclooxygenase-2 in interleukin-1-stimulated equine articular chondrocytes.
    Farley J, Sirois J, MacFarlane PH, Kombé A, Laverty S.
    Am J Vet Res; 2005 Nov 01; 66(11):1985-91. PubMed ID: 16334960
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.